BIONOMICS
Bionomics Limited engages in the discovery and development of therapeutics for cancer and diseases of the central nervous system in Australia. It has small molecule product development programs in the areas of cancer, anxiety, epilepsy, and multiple sclerosis. The company develops its lead cancer compound, BNC 105, for the treatment of solid tumors, such as breast, lung, colon, and prostate cancers. BNC 105 is a member of the class of compounds, known as vascular disruption agents or VDAs, which... shut down the blood supply within a tumor, starving the tumor and preventing its continued growth. The company has commercial partnerships with Genmab A/S; Athena Diagnostics; Laboratory Corporation of America; and Genetic Technologies, Ltd. Bionomics Limited was founded in 1999 and is based in Thebarton, Australia.
BIONOMICS
Industry:
Biotechnology Health Diagnostics Medical
Founded:
1999-01-01
Address:
Thebarton, South Australia, Australia
Country:
Australia
Website Url:
http://www.bionomics.com.au
Total Employee:
11+
Status:
Active
Contact:
61 8 8354 6100
Email Addresses:
[email protected]
Total Funding:
38.64 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Vulcan Biosciences
Vulcan Biosciences commercializes a therapy for treating multiple sclerosis (MS), a debilitating disease of the central nervous system.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-09-23 | Prestwick Chemical | Prestwick Chemical acquired by Bionomics | N/A |
| 2012-09-17 | Eclipse Therapeutics | Eclipse Therapeutics acquired by Bionomics | 10 M USD |
| 2005-05-24 | Iliad Chemicals Pty | Iliad Chemicals Pty acquired by Bionomics | 6.1 M AUD |
Investors List
Novamind
Novamind investment in Post-IPO Equity - Bionomics
Start-up Australia Ventures
Start-up Australia Ventures investment in Post-IPO Equity - Bionomics
Official Site Inspections
http://www.bionomics.com.au Semrush global rank: 6.43 M Semrush visits lastest month: 1.02 K
Unable to get host informations!!!
